1. Home
  2. PBYI vs HURC Comparison

PBYI vs HURC Comparison

Compare PBYI & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • HURC
  • Stock Information
  • Founded
  • PBYI 2010
  • HURC 1968
  • Country
  • PBYI United States
  • HURC United States
  • Employees
  • PBYI N/A
  • HURC N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • HURC Industrial Machinery/Components
  • Sector
  • PBYI Health Care
  • HURC Industrials
  • Exchange
  • PBYI Nasdaq
  • HURC Nasdaq
  • Market Cap
  • PBYI 171.7M
  • HURC 125.1M
  • IPO Year
  • PBYI N/A
  • HURC N/A
  • Fundamental
  • Price
  • PBYI $4.52
  • HURC $17.97
  • Analyst Decision
  • PBYI Strong Buy
  • HURC
  • Analyst Count
  • PBYI 1
  • HURC 0
  • Target Price
  • PBYI $7.00
  • HURC N/A
  • AVG Volume (30 Days)
  • PBYI 592.1K
  • HURC 45.1K
  • Earning Date
  • PBYI 11-06-2025
  • HURC 09-05-2025
  • Dividend Yield
  • PBYI N/A
  • HURC N/A
  • EPS Growth
  • PBYI 434.29
  • HURC N/A
  • EPS
  • PBYI 0.97
  • HURC N/A
  • Revenue
  • PBYI $238,062,000.00
  • HURC $186,789,000.00
  • Revenue This Year
  • PBYI N/A
  • HURC N/A
  • Revenue Next Year
  • PBYI N/A
  • HURC N/A
  • P/E Ratio
  • PBYI $4.65
  • HURC N/A
  • Revenue Growth
  • PBYI 8.63
  • HURC N/A
  • 52 Week Low
  • PBYI $2.32
  • HURC $13.19
  • 52 Week High
  • PBYI $6.07
  • HURC $23.76
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 51.02
  • HURC 51.85
  • Support Level
  • PBYI N/A
  • HURC N/A
  • Resistance Level
  • PBYI $5.22
  • HURC $18.40
  • Average True Range (ATR)
  • PBYI 0.24
  • HURC 0.83
  • MACD
  • PBYI -0.28
  • HURC -0.55
  • Stochastic Oscillator
  • PBYI 83.09
  • HURC 96.20

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

Share on Social Networks: